Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8334-8344
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8334
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8334
Control | Morin | CCl4 | Morin + CCl4 | F | P value | |
(n = 5) | (n = 4) | (n = 3) | (n = 4) | |||
ALT (IU/L) | 101.75 ± 15.46 | 108.00 ± 48.72 | 493.33 ± 199.38ac | 291.50 ± 111.92ace | 11.403 | 0.001 |
AST (IU/L) | 339.25 ± 72.59 | 257.80 ± 98.22 | 1027.67 ± 206.60ac | 585.50 ± 131.85ace | 26.280 | < 0.001 |
ALP (IU/L) | 137.75 ± 29.75 | 160.80 ± 40.90 | 377.67 ± 41.07ac | 266.50 ± 58.90ace | 22.093 | < 0.001 |
- Citation: Sang L, Wang XM, Xu DY, Sang LX, Han Y, Jiang LY. Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model. World J Gastroenterol 2017; 23(47): 8334-8344
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8334